SANDOZ ORPHENADRINE
SANDOZ ORPHENADRINE
Approved
DIN Number
02243559
Drug Class
Human
Market Date
Feb 27, 2001
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243559
AIG Number0102078001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M03BC01 ORPHENADRINE (CITRATE)
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification12:20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ORPHENADRINE CITRATEActive
Strength: 100 MG
Monograph: ORPHENADRINE CITRATE